SCHEMBL7600247

SCHEMBL7600247

CC(=O)Nc1cccc(CN2CCCCCC2)c1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ CYP2D6 P10635 1/20 0.57
▸ CYP2C9 P11712 1/20 0.57
▸ HIF1A Q16665 1/20 0.57
▸ BTK Q06187 1/20 0.57
▸ MEN1 O00255 1/20 0.56
▸ TSHR P16473 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ POLB P06746 1/20 0.55
▸ CDK5 Q00535 1/20 0.55
▸ CDK5R1 Q15078 1/20 0.55
▸ ACKR3 P25106 6/20 0.54
▸ CHRM3 P20309 1/20 0.54
▸ GAA P10253 1/20 0.53
▸ MAPT P10636 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10702311 0.99 KDM4E (0.67) KDM4EALDH1A1CYP2D6CYP2C9HIF1A
SCHEMBL17754101 0.86 SMN1; SMN2 (0.63) ALDH1A1HIF1ABTKMEN1TSHR
SCHEMBL30577399 0.86 SMN1; SMN2 (0.63) ALDH1A1HIF1ABTKMEN1TSHR
SCHEMBL11926135 0.86 CHRM3 (0.69) KDM4EALDH1A1BTKMEN1TSHR
SCHEMBL10551915 0.86 HTR1A (0.58) KDM4EALDH1A1KMT2APOLBGAA
SCHEMBL10556103 0.86 HTR1A (0.58) KDM4EALDH1A1KMT2APOLBGAA
SCHEMBL10552188 0.84 HTR1A (0.59) KDM4EALDH1A1BTKKMT2APOLB
SCHEMBL10515943 0.84 CDK5 (0.56) ALDH1A1CYP2D6CYP2C9HIF1APOLB
SCHEMBL14190849 0.84 KCNH2 (0.55) BTKMEN1TSHRKMT2AACKR3
SCHEMBL15156423 0.82 KDM4E (1.00) KDM4EALDH1A1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1137412-A4 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF AMERICAN BIOGENETIC SCIENCES (US) 2002-04-03 — — EP disclosed
EP-1137412-A2 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF AMERICAN BIOGENETIC SCIENCES, INC. (US) 2001-10-04 — — EP disclosed
WO-2000033788-A2 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUNDS AND THERAPEUTIC USES THEREOF AMERICAN BIOGENETIC SCIENCES INC. (US) 2000-06-15 — — WO disclosed
Send feedback